{
  "id": 16374870,
  "title": "Adlai Nortye director Ji Ping sells $163,274 in ANL stock",
  "url": "https://urgent.news/2026/10/24/adlai-nortye-director-ji-ping-sells-163-274-in-anl-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-24T21:16:28.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/adlai-nortye-director-ji-ping-sells-163274-in-anl-stock-93CH-4970965"
  },
  "original_language": "en",
  "account": null,
  "summary": "Adlai Nortye Group Ltd. (NASDAQ:ANL) Director Ji Ping sold $163,274 worth of American Depository shares over two days in late September 2026, according to a filing with the U.S. Securities and Exchange Commission. The director disposed of 10,214 shares across three separate transactions, with prices ranging from $15.77 to $16.03 per share. Despite these sales, ANL shares have since declined, while the stock has delivered exceptional returns over the past year, up 540%. Analysts have taken notice of Adlai Nortye Ltd., with firms like Jefferies and Lucid Capital Markets initiating coverage and assigning buy ratings to the company, highlighting its promising drug pipeline, particularly the AN9025 drug candidate.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}